TSE:EXE Extendicare - EXE Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$6.40 +0.09 (+1.43%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's RangeC$6.31▼C$6.4250-Day RangeC$6.08▼C$6.7752-Week RangeC$6.02▼C$8.00Volume115,417 shsAverage Volume158,280 shsMarket CapitalizationC$542.27 millionP/E RatioN/ADividend Yield7.50%Price TargetC$7.25 ProfileAnalyst RatingsChartCompetitorsDividendEarningsInsider TradesHeadlinesSocial Media Extendicare MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside13.3% UpsideC$7.25 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.20 out of 5 stars 2.0 Analyst's Opinion Consensus RatingExtendicare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$7.25, Extendicare has a forecasted upside of 13.3% from its current price of C$6.40.Amount of Analyst CoverageExtendicare has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EXE. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 7.86%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXE. Previous Next 1.1 News and Social Media Coverage News SentimentExtendicare has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Extendicare this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by Insiders13.15% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 17.47% of the stock of Extendicare is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is -128.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is -128.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioExtendicare has a P/B Ratio of 5.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Extendicare (TSE:EXE) StockExtendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.Read More Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Stock News HeadlinesMarch 25, 2023 | americanbankingnews.comExtendicare (TSE:EXE) Hits New 52-Week Low at $6.06March 15, 2023 | finance.yahoo.comExtendicare Announces March 2023 Dividend of C$0.04 per ShareApril 1, 2023 | Investorplace Media (Ad)This Tech Stock Could be the Next AmazonYou can learn its name in Luke Lango’s latest report, 5 Hypergrowth Stocks for 2023. Claim Your Free Report Here. March 2, 2023 | finance.yahoo.comExtendicare Announces 2022 Fourth Quarter and Year End ResultsFebruary 15, 2023 | finance.yahoo.comExtendicare Announces February 2023 Dividend of C$0.04 per ShareJanuary 20, 2023 | finance.yahoo.comExtendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04January 19, 2023 | finance.yahoo.comExtendicare Announces Timing of Fourth Quarter and Fiscal 2022 Results and Conference CallJanuary 16, 2023 | finance.yahoo.comExtendicare Announces January 2023 Dividend of C$0.04 per ShareApril 1, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.December 15, 2022 | finance.yahoo.comExtendicare Announces December 2022 Dividend of C$0.04 per ShareNovember 13, 2022 | finance.yahoo.comExtendicare Third Quarter 2022 Earnings: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)November 12, 2022 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) five years ago are up 10%October 19, 2022 | globenewswire.comGlobal Home Healthcare Services Market to Acquire an Impressive Revenue by 2033 and to Grow with a CAGR of - GlobeNewswireOctober 18, 2022 | benzinga.comExtendicare Announces October 2022 Dividend of C$0.04 per Share - BenzingaOctober 17, 2022 | finance.yahoo.comExtendicare Announces October 2022 Dividend of C$0.04 per ShareOctober 16, 2022 | ca.finance.yahoo.comTFSA Passive Income: Make $526/Month Tax Free With Healthcare Stocks - Yahoo Canada FinanceOctober 15, 2022 | fool.caTFSA Passive Income: Make $526/Month Tax Free With Healthcare Stocks - The Motley Fool CanadaOctober 14, 2022 | ca.finance.yahoo.com2 Top Healthcare Stocks Defying the Bear Market - Yahoo Canada FinanceOctober 13, 2022 | finance.yahoo.comDoes This Valuation Of Extendicare Inc. (TSE:EXE) Imply Investors Are Overpaying?October 13, 2022 | theglobeandmail.comExtendicare's exit in Saskatchewan heralds end of private for-profit long-term care - The Globe and MailOctober 12, 2022 | fool.ca2 Top Healthcare Stocks Defying the Bear Market - The Motley Fool CanadaOctober 7, 2022 | ca.finance.yahoo.comTrevali Announces Application for Judicial Liquidation of 90%-Owned Burkina Faso Subsidiary; Extension of CCAA Stay of Proceedings - Yahoo Canada FinanceOctober 6, 2022 | finance.yahoo.comExtendicare Announces Timing of 2022 Third Quarter Results and Conference Call - Yahoo FinanceOctober 6, 2022 | finance.yahoo.comExtendicare Announces Timing of 2022 Third Quarter Results and Conference CallOctober 1, 2022 | fool.caMy 3 Favourite TSX Stocks for Passive Income - The Motley Fool CanadaSeptember 25, 2022 | fool.caTFSA Passive Income: Make $455/Month Tax Free for Life - The Motley Fool CanadaSeptember 19, 2022 | theglobeandmail.comExtendicare: Top 10 Undervalued Healthcare Providers & Services Industry Stocks on TSE (EXE)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EXE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Company Calendar Ex-Dividend for 3/15 Dividend2/27/2023Dividend Payable3/15/2023Ex-Dividend for 4/17 Dividend3/30/2023Today4/01/2023Dividend Payable4/17/2023Next Earnings (Estimated)5/11/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Long - Term Care Facilities Sub-IndustryN/A SectorMedical Current SymbolTSE:EXE CUSIPN/A CIKN/A Webwww.extendicare.com Phone905-470-4000FaxN/AEmployees23,000Year FoundedN/APrice Target and Rating Average Stock Price ForecastC$7.25 High Stock Price ForecastC$8.00 Low Stock Price ForecastC$7.00 Forecasted Upside/Downside+13.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E Ratio35.11 P/E GrowthN/ANet IncomeC$-4,510,000.00 Net Margins5.69% Pretax MarginN/A Return on Equity-4.45% Return on Assets1.92% Debt Debt-to-Equity Ratio381.30 Current Ratio0.94 Quick Ratio0.98 Sales & Book Value Annual SalesC$1.22 billion Price / Sales0.44 Cash FlowC$2.00 per share Price / Cash Flow3.20 Book ValueC$1.19 per share Price / Book5.38Miscellaneous Outstanding Shares84,730,000Free FloatN/AMarket CapC$542.27 million OptionableNot Optionable Beta1.19 Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, Pres & Director Comp: $1.13MMr. David E. BaconSr. VP & CFOMr. John ToffolettoSr. VP, Chief Legal Officer & Corp. Sec.Ms. Leslie Sarauer (Age 61)Sr. VP & Chief HR Officer Comp: $567.15kMr. Ali Mohammad MirVP, ParaMed OperationsMr. Steve ParaskevopoulosSr. VP of ParaMed & CTOMs. Jillian E. FountainVP of Investor RelationsMs. Lisa PearsonVP of Public AffairsMs. Elaine E. EversonVP of Corp. Devel.Dr. Matthew MorganChief Medical OfficerMore ExecutivesKey CompetitorsSienna Senior LivingTSE:SIAKnight TherapeuticsTSE:GUDViemed HealthcareTSE:VMDSernovaCVE:SVACRH MedicalTSE:CRHView All Competitors EXE Stock - Frequently Asked Questions Should I buy or sell Extendicare stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Extendicare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" EXE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXE, but not buy additional shares or sell existing shares. View EXE analyst ratings or view top-rated stocks. What is Extendicare's stock price forecast for 2023? 3 brokers have issued 12 month price targets for Extendicare's stock. Their EXE share price forecasts range from C$7.00 to C$8.00. On average, they anticipate the company's share price to reach C$7.25 in the next year. This suggests a possible upside of 13.3% from the stock's current price. View analysts price targets for EXE or view top-rated stocks among Wall Street analysts. How have EXE shares performed in 2023? Extendicare's stock was trading at C$6.56 on January 1st, 2023. Since then, EXE stock has decreased by 2.4% and is now trading at C$6.40. View the best growth stocks for 2023 here. When is Extendicare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023. View our EXE earnings forecast. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare announced a monthly dividend on Wednesday, March 15th. Stockholders of record on Friday, March 31st will be paid a dividend of 0.04 per share on Monday, April 17th. This represents a $0.48 dividend on an annualized basis and a yield of 7.50%. The ex-dividend date is Thursday, March 30th. Read our dividend analysis for EXE. Is Extendicare a good dividend stock? Extendicare (TSE:EXE) pays an annual dividend of C$0.48 per share and currently has a dividend yield of 7.86%. EXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for EXE. What other stocks do shareholders of Extendicare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Extendicare investors own include Inter Pipeline (IPL), Pembina Pipeline (PPL), BCE (BCE), Chorus Aviation (CHR), Cenovus Energy (CVE), Medical Facilities (DR), Martinrea International (MRE), Air Canada (AC), AltaGas (ALA) and Emera (EMA). What is Extendicare's stock symbol? Extendicare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EXE." How do I buy shares of Extendicare? Shares of EXE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Extendicare's stock price today? One share of EXE stock can currently be purchased for approximately C$6.40. How much money does Extendicare make? Extendicare (TSE:EXE) has a market capitalization of C$542.27 million and generates C$1.22 billion in revenue each year. The company earns C$-4,510,000.00 in net income (profit) each year or C($0.05) on an earnings per share basis. How many employees does Extendicare have? The company employs 23,000 workers across the globe. How can I contact Extendicare? The official website for the company is www.extendicare.com. The company can be reached via phone at 905-470-4000. This page (TSE:EXE) was last updated on 4/1/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.